DiaSorin SpA (DIAS.MI)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|80||2007||Chairman, Non-Executive Director|
|51||2006||Chief Executive Officer, Executive Director, General Manager|
|48||2013||Vice Chairman, Non-Executive Director|
|46||2016||Senior Corporate VP and Chief Financial Officer|
|57||2007||Senior Corporate Vice President - Human Resources|
- BRIEF-Diasorin Receives CE Mark For A New Bordetella Molecular Diagnostic Test
- BRIEF-DiaSorin Q3 net profit up at EUR 29.3 mln, confirms 2017 guidance
- BRIEF-Diasorin revises its FY 2019 guidance
- BRIEF-DiaSorin completes acquisition of Elisa immunodiagnostic business portfolio
- BRIEF-DiaSorin earns CE-mark extending sample claims for its Simplexa HSV 1&2 kit